2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

被引：76

作者：

Kondoh, Yasuhiro ^{[1
]}

Makino, Shigeki ^{[2
]}

Ogura, Takashi ^{[3
]}

Suda, Takafumi ^{[4
]}

Tomioka, Hiromi ^{[5
]}

Amano, Hirofumi ^{[6
]}

Anraku, Masaki ^{[7
,8
]}

Enomoto, Noriyuki ^{[9
]}

Fujii, Takao ^{[10
]}

Fujisawa, Tomoyuki ^{[4
]}

Gono, Takahisa ^{[11
]}

Harigai, Masayoshi ^{[12
]}

Ichiyasu, Hidenori ^{[13
]}

Inoue, Yoshikazu ^{[14
]}

Johkoh, Takeshi ^{[15
]}

Kameda, Hideto ^{[16
]}

Kataoka, Kensuke ^{[1
]}

Katsumata, Yasuhiro ^{[12
]}

Kawaguchi, Yasushi ^{[12
]}

Kawakami, Atsushi ^{[17
]}

Kitamura, Hideya ^{[3
]}

Kitamura, Noboru ^{[18
]}

Koga, Tomohiro ^{[17
]}

Kurasawa, Kazuhiro ^{[19
]}

Nakamura, Yutaro ^{[4
]}

Nakashima, Ran ^{[20
]}

Nishioka, Yasuhiko ^{[21
]}

Nishiyama, Osamu ^{[22
]}

Okamoto, Masaki ^{[23
]}

Sakai, Fumikazu ^{[24
]}

Sakamoto, Susumu ^{[25
]}

Sato, Shinji ^{[26
]}

Shimizu, Toshimasa ^{[17
]}

Takayanagi, Noboru ^{[27
]}

Takei, Reoto ^{[1
]}

Takemura, Tamiko ^{[28
]}

Takeuchi, Tohru ^{[29
]}

Toyoda, Yuko ^{[30
]}

Yamada, Hidehiro ^{[31
]}

Yamakawa, Hideaki ^{[32
]}

Yamano, Yasuhiko ^{[1
]}

Yamasaki, Yoshioki ^{[11
]}

Kuwana, Masataka ^{[11
]}

机构：

[1] Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan

[2] Osaka Med Coll Mishima, Rheumatol Div, Minami Hosp, Takatsuki, Osaka, Japan

[3] Kanagawa Cardiovasc & Resp Ctr, Div Resp Med, Yokohama, Kanagawa, Japan

[4] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Shizuoka, Japan

[5] Kobe City Med Ctr, Dept Resp Med, West Hosp, Kobe, Hyogo, Japan

[6] Juntendo Univ, Dept Internal Med & Rheumatol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan

[7] Tokyo Metropolitan Geriatr Hosp, Dept Thorac Surg, Itabashi Ku, Tokyo, Japan

[8] Inst Gerontol, Itabashi Ku, Tokyo, Japan

[9] Hamamatsu Univ Sch Med, Hlth Adm Ctr, Hamamatsu, Shizuoka, Japan

[10] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Wakayama, Japan

[11] Nippon Med Sch, Dept Allergy & Rheumatol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan

[12] Tokyo Womens Med Univ, Dept Rheumatol, Sch Med, Shinjuku Ku, Tokyo, Japan

[13] Kumamoto Univ, Fac Life Sci, Dept Resp Med, Kumamoto, Kumamoto, Japan

[14] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Sakai, Osaka, Japan

[15] Kansai Rosai Hosp, Dept Radiol, Amagasaki, Hyogo, Japan

[16] Toho Univ, Fac Med, Dept Internal Med, Div Rheumatol,Meguro Ku, Tokyo, Japan

[17] Nagasaki Univ, Dept Immunol & Rheumatol, Div Adv Prevent Med Sci, Grad Sch Biomed Sci, Nagasaki, Nagasaki, Japan

[18] Nihon Univ, Dept Med, Div Hematol & Rheumatol, Sch Med, Tokyo, Japan

[19] Dokkyo Med Univ, Dept Rheumatol, Mibu, Tochigi, Japan

[20] Kyoto Univ, Grad Sch Med, Rheumatol & Clin Immunol, Sakyo Ku, Kyoto, Japan

[21] Tokushima Univ, Grad Sch Biomed Sci, Dept Resp Med & Rheumatol, Tokushima, Tokushima, Japan

[22] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osakasayama, Osaka, Japan

[23] Natl Hosp Org Kyushu Med Ctr, Dept Respirol, Fukuoka, Fukuoka, Japan

[24] Saitama Med Univ, Saitama Int Med Ctr, Dept Diagnost Radiol, Hidaka, Saitama, Japan

[25] Toho Univ, Dept Resp Med, Omori Med Ctr, Tokyo, Japan

[26] Tokai Univ, Dept Internal Med, Div Rheumatol, Sch Med, Isehara, Kanagawa, Japan

[27] Saitama Cardiovasc & Resp Ctr, Dept Resp Med, Kumagaya, Saitama, Japan

[28] Kanagawa Cardiovasc & Resp Ctr, Dept Pathol, Yokohama, Kanagawa, Japan

[29] Osaka Med & Pharmaceut Univ, Dept Internal Med 4, Takatsuki, Osaka, Japan

[30] Japanese Red Cross Kochi Hosp, Dept Resp Med, Kochi, Kochi, Japan

[31] Seirei Yokohama Hosp, Ctr Rheumat Dis, Yokohama, Kanagawa, Japan

[32] Saitama Red Cross Hosp, Dept Resp Med, Saitama, Saitama, Japan

来源：

RESPIRATORY INVESTIGATION | 2021年 / 59卷 / 06期

基金：

日本学术振兴会;

关键词：

Rheumatoid arthritis; Systemic sclerosis; Myositis; Immunosuppressant; Antifibrotic agent; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; IMMOBILIZED FIBER COLUMN; ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; INTRAVENOUS PULSE CYCLOPHOSPHAMIDE; PULMONARY ARTERIAL-HYPERTENSION; HEALTH-ASSESSMENT QUESTIONNAIRE; STEM-CELL TRANSPLANTATION; ANTITUMOR NECROSIS FACTOR; SURFACTANT PROTEIN-D;

D O I：

10.1016/j.resinv.2021.04.011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The prognosis of patients with connective tissue disease (CTD) has improved significantly in recent years, but interstitial lung disease (ILD) associated with connective tissue disease (CTD-ILD) remains a refractory condition, which is a leading cause of mortality. Because it is an important prognostic factor, many observational and interventional studies have been conducted to date. However, CTD is a heterogeneous group of conditions, which makes the clinical course, treatment responses, and prognosis of CTD-ILD extremely diverse. To summarize the current understanding and unsolved questions, the Japanese Respiratory Society and the Japan College of Rheumatology collaborated to publish the world's first guide focusing on CTD-ILD, based on the evidence and expert consensus of pulmonologists and rheumatologists, along with radiologists, pathologists, and dermatologists. The task force members proposed a total of 27 items, including 7 for general topics, 9 for disease-specific topics, 3 for complications, 4 for pharmacologic treatments, and 4 for non-pharmacologic therapies, with teams of 2-4 authors and reviewers for each item to prepare a consensus statement based on a systematic literature review. Subsequently, public opinions were collected from members of both societies, and a critical review was conducted by external reviewers. Finally, the task force finalized the guide upon discussion and consensus generation. This guide is expected to contribute to the standardization of CTD-ILD medical care and is also useful as a tool for promoting future research by clarifying unresolved issues. (C) 2021 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

引用

页码：709 / 740

页数：32

共 240 条

[1] Neutrophil Adsorption by Polymyxin B-Immobilized Fiber Column for Acute Exacerbation in Patients with Interstitial Pneumonia: A Pilot Study
Abe, Shinji
Seo, Yoshitsugu
Hayashi, Hiroki
Matsuda, Kuniko
Usuki, Jiro
Azuma, Arata
Kudoh, Shoji
Gemma, Akihiko
[J]. BLOOD PURIFICATION, 2010, 29 (04) : 321 - 326
[2] Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Aggarwal, Rohit
Cassidy, Elaine
Fertig, Noreen
Koontz, Diane Carol
Lucas, Mary
Ascherman, Dana P.
Oddis, Chester V.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 227 - 232
[3] Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients
Akira, M
Hara, H
Sakatani, M
[J]. RADIOLOGY, 1999, 210 (02) : 333 - 338
[4] Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis - A multicenter, case-control study
Alarcon, GS
Kremer, JM
Macaluso, M
Weinblatt, ME
Cannon, GW
Palmer, WR
StClair, EW
Sundy, JS
Alexander, RW
Smith, GJW
Axiotis, CA
[J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (05) : 356 - +
[5] American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, Am J Respir Crit Care Med, V165, P277, DOI DOI 10.1164/AJRCCM.165.2.ATS01
[6] Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease
Andersson, Helena
Sem, Marthe
Lund, May Brit
Aalokken, Trond Mogens
Gunther, Anne
Walle-Hansen, Ragnhild
Garen, Torhild
Molberg, Oyvind
[J]. RHEUMATOLOGY, 2015, 54 (08) : 1420 - 1428
[7] [Anonymous], 2016, IDIOPATHIC INTERSTIT, V3rd
[8] TREATMENT OF SEPSIS BY EXTRACORPOREAL ELIMINATION OF ENDOTOXIN USING POLYMYXIN B-IMMOBILIZED FIBER
AOKI, H
KODAMA, M
TANI, T
HANASAWA, K
[J]. AMERICAN JOURNAL OF SURGERY, 1994, 167 (04) : 412 - 417
[9] Arai S, 2013, MOD RHEUMATOL, V23, P872, DOI [10.1007/s10165-012-0756-0, 10.3109/s10165-012-0756-0]
[10] Arimura Y, 2017, RES PROJECT OVERCOMI

← 1 2 3 4 5 6 7 8 9 10 →